Pain With Dementia (PWD)

December 2, 2025 updated by: Duke University

Caregiver-assisted Pain Coping Skills Training for Dementia Pilot Study

The purpose of the study is to develop a caregiver-assisted pain coping skills training program for older adults who have pain and mild to moderate dementia and are living at home with a family caregiver. The investigators are planning to recruit 30 patient-caregiver dyads (60 individuals).

Study Overview

Detailed Description

Involving caregivers in a pain coping skills protocol is likely to optimize treatment outcomes in several ways.

First, people with dementia (PWD) are likely to have difficulty learning and remembering pain coping skills; training the caregiver to coach the patient in the use of the skills is likely to improve the patients' acquisition and ongoing use of learned skills.

Second, caregiver involvement in pain coping skills training may increase their understanding of how to gauge how much pain the PWD is experiencing and the impact of pain management strategies. This understanding is increasingly important as the patient's disease progresses, and s/he is less able to report pain verbally.

Third, caregiver-assisted pain management training may enhance caregivers' self-confidence for managing the patient's pain.

Finally, by participating in the pain coping skills training protocol, caregivers may learn coping skills (such as relaxation) that can help them manage the stress associated with caring for a PWD and pain which can be significant.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27705
        • Recruiting
        • Duke University Medical Center
        • Contact:
        • Principal Investigator:
          • Laura Porter, Ph.D
        • Principal Investigator:
          • Katherine Ramos, Ph.D

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Patients:

  • Mild or moderate dementia
  • Pain on most days for at least 3 months that interferes with function
  • Living at home (non-institutional)
  • Age ≥ 50
  • English Speaking

Caregivers:

  • Provides on average at least 4 hours/day of care/assistance to the patient
  • Age ≥ 18
  • English Speaking

Exclusion Criteria:

Patient and caregivers

  • Lacking capacity for interview or unable to provide informed consent/assent.
  • Visual or hearing impairments or severe behavioral problems that preclude participation.
  • Too sick to participate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Patient-Caregiver Dyads
Patient and caregiver dyads will receive five 45-60 minute sessions over 6-8 week period. This will be over videoconference with a masters-level therapist. All sessions will be audio recorded.
Patient-caregiver dyads will receive five, forty-to-sixty-minute sessions over a six-to-eight-week period with a therapist to learn pain coping skills. These include training caregivers in strategies for assessing patient pain, including nonverbal pain behaviors (e.g., grimacing, bodily tension, labored breathing), which will become increasingly important as the patient's ability to express pain verbally decreases. The therapist will also train the caregiver to coach the patient in the use of the skills during activities that are challenging because of pain. We will focus on increasing positive patient-caregiver interactions and patient engagement in valued activities. Throughout the training, the therapist will help the patient and caregiver learn strategies for fostering regular home practice and application of the skills, identify challenges in using the skills, and find strategies for coping with challenges.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Client Satisfaction Questionnaire
Time Frame: Post-intervention (approximately 8 weeks)
Caregiver completes. Score range: 1-4; higher score indicates better outcome
Post-intervention (approximately 8 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life in Alzheimer's Disease Caregiver version and Patient version
Time Frame: Baseline and post-intervention (approximately 8 weeks)
Patient and Caregiver will complete Patient QOL. Score range: 13-52; higher score indicates better outcome
Baseline and post-intervention (approximately 8 weeks)
Brief Pain Inventory-Interference Items
Time Frame: Baseline and post-intervention (approximately 8 weeks)
Patient and Caregiver will complete Patient pain interference. Score range: 0-10; higher score indicates worse outcome
Baseline and post-intervention (approximately 8 weeks)
Caregiver Self-Efficacy in Pain Management
Time Frame: Baseline and post-intervention (approximately 8 weeks)
Caregiver will complete caregiver self-efficacy. Score range: 0-10; higher score indicates better outcome
Baseline and post-intervention (approximately 8 weeks)
Numeric pain scale & verbal descriptor
Time Frame: Baseline and post-intervention (approximately 8 weeks)
Patient will complete patient pain intensity. Score range: 0-19; higher score indicates worse outcome
Baseline and post-intervention (approximately 8 weeks)
Checklist of nonverbal pain indicators
Time Frame: Baseline and post-intervention (approximately 8 weeks)
Caregiver will complete patient pain intensity. Score range: 0-10; higher score indicates worse outcome
Baseline and post-intervention (approximately 8 weeks)
Zarit burden interview
Time Frame: Baseline and post-intervention (approximately 8 weeks)
Caregivers will complete caregiver burden. Score range: 0-88; higher score indicates worse outcome
Baseline and post-intervention (approximately 8 weeks)
Caregiver appraisal-satisfaction scale
Time Frame: Baseline and post-intervention (approximately 8 weeks)
Caregiver will complete caregiver satisfaction. Score range: 0-10; higher score indicates worse outcome
Baseline and post-intervention (approximately 8 weeks)
Neuropsychiatric inventory
Time Frame: Baseline and post-intervention (approximately 8 weeks)
Caregiver will complete patient neuropsychiatry behaviors. Score range: 0-144; higher score indicates worse outcome
Baseline and post-intervention (approximately 8 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Laura Porter, Ph.D, Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 13, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

February 10, 2025

First Submitted That Met QC Criteria

February 25, 2025

First Posted (Actual)

March 3, 2025

Study Record Updates

Last Update Posted (Estimated)

December 3, 2025

Last Update Submitted That Met QC Criteria

December 2, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Caregiver-Assisted Pain Coping Skills Training (CG-PCST)

Subscribe